Northwestern Medicine scientists have uncovered a biological mechanism that helps explain why most patients with glioblastoma fail to respond to immunotherapy, according to their study published in Nature Communications.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗